20 results
8-K
EX-99.1
ACST
Acasti Pharma Inc.
25 Sep 24
Acasti Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104
8:00am
, non-greasy application. It also comes in convenient, portable 30 ml plastic bottles. Unlike oral gabapentin and lidocaine patches, we believe
8-K
EX-99.1
ACST
Acasti Pharma Inc.
9 Aug 24
Acasti Announces First Fiscal Quarter 2025 Financial Results, Provides Business Update
8:00am
plastic bottles. Unlike oral gabapentin and lidocaine patches, we believe that the biphasic delivery mechanism of GTX-101 has the potential for rapid onset
8-K
EX-99.1
ACST
Acasti Pharma Inc.
21 Jun 24
Acasti Announces Year-End 2024 Financial Results, Provides Business Update
8:00am
. It also comes in convenient, portable 30 ml plastic bottles. Unlike oral gabapentin and lidocaine patches, we believe that the biphasic delivery
424B5
dy711m6b vp50k6
10 Nov 21
Prospectus supplement for primary offering
7:23am
424B3
ni6d2
15 Jul 21
Prospectus supplement
4:45pm
S-4/A
72ac ar3u
13 Jul 21
Registration of securities issued in business combination transactions (amended)
4:41pm
S-4
4ad6abcafo e5v
1 Jul 21
Registration of securities issued in business combination transactions
12:00am
8-K
EX-99.2
8gybrapt4146h
7 May 21
Entry into a Material Definitive Agreement
7:09am
425
EX-99.2
e2z 0n35djg
7 May 21
Business combination disclosure
7:08am
- Prev
- 1
- Next